Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics
about
sameAs
Multidrug Resistance Is Common in Escherichia coli Associated with Ileal Crohnʼs DiseaseTranslocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiersComplete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82.Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo.Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease.The role of bacteria in the pathogenesis of inflammatory bowel diseaseNucleotide-binding oligomerization domain-containing protein 2 controls host response to Campylobacter jejuni in Il10-/- mice.Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer.Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn's disease.Gentamicin supplemented polyvinylidenfluoride mesh materials enhance tissue integration due to a transcriptionally reduced MMP-2 protein expression.Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin DHost-bacteria interaction in inflammatory bowel disease.Candidate genes involved in beneficial or adverse responses to commonly eaten brassica vegetables in a New Zealand Crohn's disease cohort.Importance of disrupted intestinal barrier in inflammatory bowel diseases.Lessons from diversion studies and antibacterial interventions.The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease.GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.Activity of Species-specific Antibiotics Against Crohn's Disease-Associated Adherent-invasive Escherichia coli.Defective macrophage handling of Escherichia coli in Crohn's disease.Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile.Antimicrobial resistance impacts clinical outcome of granulomatous colitis in boxer dogs.Crohn's disease as an immunodeficiency.Defects in autophagy favour adherent-invasive Escherichia coli persistence within macrophages leading to increased pro-inflammatory response.Successful treatment of vaginal malakoplakia in a young cat.Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease.Glucocorticoids Impair Phagocytosis and Inflammatory Response Against Crohn's Disease-Associated Adherent-Invasive Escherichia coli.
P2860
Q22252899-38608342-275D-45A1-9D1E-61F9669343F5Q24611219-638CBB2E-3E0A-4902-B371-20C08037473FQ33700512-11997829-1197-4CA1-BD11-763801A3363CQ33730054-58267BA8-2CDC-4022-8444-06FBC365A4ECQ33958858-4F66BC12-EAD9-489E-B356-53B010249D33Q34206639-FD185630-A91C-429F-AA10-255E20DE07C9Q34209010-FFAA2E37-58B4-4E02-B078-337F41ADFD30Q34813547-750B8DA1-9A97-4625-B2C5-41CF128E0380Q34976841-75798DAF-BB5E-4407-9DE4-785976D27E09Q35681646-C3AF7F35-2C42-447C-AE5F-BD5945AE1AD3Q35812185-23843A0C-4D80-470B-9047-417BD0491D06Q36973431-54AA77A3-28FC-4C15-B9D0-8EB92659F84DQ37302559-5D6C8753-A47F-4C3F-BFF8-B73CF14108B5Q37420522-CA4F7C9F-BABF-4C04-8442-B0C89543DD4FQ37781315-70E03BD1-49D4-4747-BF51-47C208FE3515Q38026392-14C51FA6-8FCC-4F7E-B29F-65939988345EQ38648792-BE14D38E-0F76-4B60-ABCE-A7A3BFCA4935Q40381056-B79E7742-1A24-4C19-A7F5-F8E9E06F3FA0Q41107171-E677983D-A0B8-4FC6-88B3-8786299223E6Q41159798-FAB260F4-54C6-47AB-9714-DE815429A3EAQ41387395-EF52ACD7-3BB9-4B5C-9E30-A9DD157CBD75Q43056997-4D020556-0ABB-40E1-A3F4-067FB4ED94A4Q43203641-4648DEB6-AE69-4B49-B2F0-88EE7D309B04Q50503026-338832DF-6965-42BA-892A-7173180B02F4Q53301206-89022002-9D25-4B47-B348-B04F37644B66Q54359276-CA67C5BF-6465-4CEC-B8B9-4A165711BCD5Q55354007-5A1581A1-D64F-4F8A-871D-9209875939F0
P2860
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@ast
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@en
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@en-gb
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@nl
type
label
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@ast
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@en
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@en-gb
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@nl
prefLabel
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@ast
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@en
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@en-gb
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@nl
P2093
P2860
P921
P356
P1476
Replication of Colonic Crohn's ...... Susceptibility to Antibiotics
@en
P2093
C Anthony Hart
Carol L Roberts
Helen M Martin
Jonathan M Rhodes
Sreedhar Subramanian
Steve W Edwards
P2860
P304
P356
10.1128/AAC.00375-07
P407
P577
2007-12-10T00:00:00Z